announced

13th Edition of Tiger Cup 2025, Supported by Cycle Pure Agarbathi, Kicks Off with Debut of Girls' League

Cycle Pure Agarbathi inaugurates the 13th edition of the Tiger Cup 2025, a cricket tournament for the under 12, under…

2 months ago

Edesa Biotech Announces Upcoming Conference Schedule

TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics…

2 months ago

Lucas GC Limited Announces 1H 2025 Financial Results: Revenue at US$54.01 million with Increases in Gross Margin

October 31, 2025 17:00 ET  | Source: Lucas GC Limited NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Lucas GC…

2 months ago

Elevaris Medical Devices Names New Chief Engineering and Operations Officer

BOSTON, Oct. 31, 2025 /PRNewswire/ -- Elevaris Medical Devices, a Contract Development and Manufacturing Organization for industry-leading multi-national healthcare companies,…

2 months ago

Star Health Reports 21% YoY Profit Growth to 518 Cr; COR Improves by 170 bps in H1FY26 under IFRS

24% growth in fresh retail premiums Expense ratio improves to 29.7% from 31.1% (IFRS) CHENNAI, India, Oct. 29, 2025 /PRNewswire/…

2 months ago

Max India Limited's Rights Issue: 1.45 Times Oversubscription Signals Strong Investor Confidence

Max India Limited (MIL) has announced the successful closure of its Rights Issue, raising Rs. 124.23 crore through the issuance…

2 months ago

Hyundai Motor Group Announces NVIDIA Blackwell AI Factory to Power Fleet of AIDriven Mobility Solutions

Hyundai Motor Group and NVIDIA will collaborate with the Korean government to develop Korea’s physical AI industry, including the establishment…

2 months ago

Kia Announces 2025 Third Quarter Business Results

Kia posts Q3 revenue of KRW 28.69 trillion, up 8.2% Y/yQ3 global sales of 785,137 units, up 2.8% Y/yQ3 operating…

2 months ago

CORRECTION Micron Announces Participation in Investor Event

BOISE, Idaho, Oct. 30, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Thursday, October 30th…

2 months ago

ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal Antibody for Respiratory Syncytial Virus Infection

SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced the initiation of a Phase II…

2 months ago